Legal Representation
Attorney
Emily R. Billig
USPTO Deadlines
Next Deadline
10 days remaining
Published for Opposition
Due Date
January 08, 2026
Extension Available
Until February 08, 2026
Application History
15 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 9, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 9, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 3, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 14, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Nov 7, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Nov 7, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Nov 7, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 29, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 29, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 29, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 18, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 5, 2025 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Aug 5, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 18, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jul 18, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 041
Arranging and conducting of conferences and congresses in the field of diabetes research; Arranging and conducting of educational conferences and congresses in the field of diabetes; Arranging and conducting of conferences and congresses in the field of advocacy regarding public awareness of diabetes, diabetes research, and treatments, preventions and cures for diabetes
Additional Information
Design Mark
The mark consists of the words "BREAKTHROUGH T1D" and “CLINICAL & RESEARCH CONGRESS” with a semicircle of rays radiating out around the left side of the "B" in "BREAKTHROUGH" and “C” in CLINICAL.
Pseudo Mark
BREAKTHROUGH T ONE D CLINICAL AND RESEARCH CONGRESS
Classification
International Classes
041
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"T1D" and "CLINICAL & RESEARCH CONGRESS"